- Home
- BILI vs RVTY Comparison
BILI vs RVTY Comparison
Compare BILI & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BILI | RVTY |
|---|---|---|
| Founded | 2009 | 1937 |
| Country | China | United States |
| Employees | 8088 | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 11.8B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | BILI | RVTY |
|---|---|---|
| Price | $22.09 | $86.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 16 |
| Target Price | $31.13 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 1.9M | 800.6K |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $11.77 | $6.37 |
| Revenue Next Year | $9.59 | $5.10 |
| P/E Ratio | $122.37 | ★ $45.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.16 | $81.36 |
| 52 Week High | $36.40 | $118.30 |
Technical Indicators
Market Signals| Indicator | BILI | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 34.98 | 41.96 |
| Support Level | $21.84 | $83.22 |
| Resistance Level | $25.65 | $88.60 |
| Average True Range (ATR) | 0.63 | 3.20 |
| MACD | 0.01 | 0.31 |
| Stochastic Oscillator | 6.44 | 29.76 |
Price Performance
Historical ComparisonAbout BILI Bilibili Inc.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing service. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, or ACG, catering primarily to Generation Z users. Over time, the platform has expanded its content ecosystem to cover a broader range of interests, successfully attracting a more diverse audience beyond its original Gen Z base.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.